Amlodipine Tablets 2.5mg (Amlodipine Tablets “Sawai”® / アムロジピン錠2.5mg「サワイ」)

JPY ¥1,900

Japanese long-acting calcium antagonist antihypertensive and antianginal agent (Amlodipine Besilate 2.5mg). Oral tablet for once-daily administration in hypertension and angina pectoris. 100 tablets (10 tablets x 10). Mfd. by Sawai Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥1,748
10 - 19 12% JPY ¥1,672
20 + 18% JPY ¥1,558
SKU: AML-25-TAB Category:

Description

Product Overview / 商品概要

Amlodipine Tablets 2.5mg “Sawai” (アムロジピン錠2.5mg「サワイ」)
Generic: Amlodipine Besilate / アムロジピンベシル酸塩
Therapeutic Category: Long-acting Calcium Antagonist / Antihypertensive and Antianginal Agent / 持続性Ca拮抗剤 高血圧症・狭心症治療剤
Manufactured by: Sawai Pharmaceutical Co., Ltd. / 沢井製薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Amlodipine Besilate (JP) 3.47mg (equivalent to Amlodipine 2.5mg) per tablet / 1錠中 日局アムロジピンベシル酸塩 3.47mg(アムロジピンとして2.5mg)
Additives: Carnauba wax, Microcrystalline cellulose, Titanium oxide, Magnesium stearate, Talc, Sodium starch glycolate, Hypromellose, Macrogol 6000, Calcium hydrogen phosphate / カルナウバロウ、結晶セルロース、酸化チタン、ステアリン酸Mg、タルク、デンプングリコール酸Na、ヒプロメロース、マクロゴール6000、リン酸水素Ca
Appearance: White to slightly yellowish-white film-coated tablet; diameter 6.1mm, thickness 3.0mm, weight approx. 104mg; imprint: SW Amlodipine 2.5
外観: 白色~微黄白色、フィルムコーティング錠、直径6.1mm、厚さ3.0mm、重量約104mg、本体表示: SW アムロジピン 2.5

Indications / 効能効果

EN: Hypertension; Angina pectoris
JA: ○高血圧症
○狭心症

Dosage and Administration / 用法用量

EN: Hypertension: Adults: 2.5–5mg of amlodipine orally once daily. Dose may be adjusted as appropriate; may be increased up to 10mg once daily if response is insufficient. Children (6 years and older): 2.5mg of amlodipine orally once daily; adjust as appropriate based on age, body weight, and symptoms.
Angina pectoris: Adults: 5mg of amlodipine orally once daily; adjust as appropriate based on symptoms.
JA: 高血圧症: 通常、成人にはアムロジピンとして2.5~5mgを1日1回経口投与する。なお、症状に応じ適宜増減するが、効果不十分な場合には1日1回10mgまで増量することができる。通常、6歳以上の小児には、アムロジピンとして2.5mgを1日1回経口投与する。なお、年齢、体重、症状により適宜増減する。
狭心症: 通常、成人にはアムロジピンとして5mgを1日1回経口投与する。なお、症状に応じ適宜増減する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to dihydropyridine compounds
JA: ジヒドロピリジン系化合物に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 22000AMX00990000
Sales Started: July 2008 / 2008年7月
Classification Code: 872171
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets (10 tablets x 10) / 100錠(10錠×10)
Other Available Packages (by special order): PTP blister: 100 tablets (10 tablets x 10), 500 tablets (10 tablets x 50)
Bulk: 500 tablets

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Amlodipine Tablets 2.5mg (Amlodipine Tablets “Sawai”® / アムロジピン錠2.5mg「サワイ」)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Amlodipine Tablets 2.5mg (Amlodipine Tablets "Sawai"®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.